Subscribe to RSS - diabetes supplies

diabetes supplies

Mandatory mail order? Seniors concerned

 - 
01/24/2013

ALEXANDRIA, Va. – A survey that suggests seniors are leery of mandatory mail-order pharmacy services may cast a long shadow on Medicare’s national mail-order program for diabetes supplies.

Glooko receives FDA clearance, hires CEO

 - 
01/18/2013

PALO ALTO, Calif. – In a busy week, Glooko saw one of its diabetes monitoring apps get FDA clearance, and announced the hiring of a new CEO, according to news reports.

Moderate growth expected for diabetes market, study says

 - 
01/15/2013

TORONTO – The U.S. market for diabetes care devices is expected to grow to nearly $16 billion by 2017, according to a new study from Millennium Research Group, a research organization specializing in medical technology market intelligence.

Box: Diabetes supply

 - 
10/24/2012

RADICAL REVAMP

Diabetes market in transition

Stakeholders see an uptick in interest toward related markets, such as ostomy, urology, wound care
 - 
10/24/2012

Nowhere is the impact of Medicare competitive bidding more evident than in diabetes supply. 

OIG work plan includes several new reviews for DME

 - 
10/03/2012

WASHINGTON – What durable medical equipment will bear the brunt of the Office of Inspector General’s (OIG’s) scrutiny next year? Diabetes supplies.

DME MACs issue re-supply guidance

 - 
09/25/2012

BALTIMORE – As promised, the four CMS medical directors have released an FAQ on re-supplies. CMS announced in a June bulletin that items that need periodic replacement, like CPAP supplies, must be non-functioning.

IR: 'Will they do it for other products?'

 - 
07/06/2012

YARMOUTH, Maine – CMS's plan to use inherent reasonableness (IR) to set prices for retail diabetes supplies could be a sign of things to come, say industry stakeholders.

IR makes a comeback?

CMS proposes using inherent reasonableness to set payment amounts for non-mail-order diabetes supplies
 - 
06/25/2012

WASHINGTON – CMS announced late on Friday that it plans to host a public meeting next month to consult with stakeholders on adjusting Medicare payment amounts for non-mail order diabetes supplies.

More bad news for AmMed

 - 
05/24/2012

NASHVILLE, Tenn. – AmMed Direct will pay $18 million to settle claims that it used a “bait-and-switch” scheme for diabetes testing supplies.

Pages